i think the NASH data at this conference could be
Post# of 148165
on oncology, i think there is a chance that Pestell gets re-engaged. I know some people don't like him, but he is incredibly impressive in my opinion - and motivated by shares to make this thing work. I think he's a key asset for us, and i for one was excited to see him come back.
moving down the line, gestalt made a great point about the HIV potential - that this indication alone could send us to $10-20 / share. what i have no clarity on whatsoever is where we are with the BLA. Are we close?
Regardless, i'm as bullish as i have ever been, and have added as many shares as i can afford.